NIO Inc.

NIO Inc. (NYSE: NIO) engages in China's premium electric car sector. The firm develops, co-manufactures, and distributes smart and connected luxury electric cars, pushing innovation in next-generation technologies like connectivity, autonomous driving, and artificial intelligence. Its models include the EP9 supercar, ES8, ES6, and EC6.

Key Highlights

• The company reported a 116.64% increase in total revenues to RMB 9.81 billion in Q3FY21 (ended September 30, 2021) compared to RMB 4.53 billion in Q3FY20.
• NIO reported a decline in net losses to RMB 0.84 billion in Q3FY21 from RMB 1.05 billion in Q3FY20.
• The company shipped 3,667 vehicles in October 2021, a 27.5% decline YoY owing to manufacturing line improvements, preparation for new product releases, and significant supply chain volatility.
• The company's ROE and net margins were -11.3% and -8.5% in Q3FY21 vs. the industry median of 1.8% and 6.4%, respectively.
• The stock is currently trading between its critical short-term (50-day) and long-term (200-day) DMA support levels, with the RSI Index at 45.92.
• It is leaning towards the lower band of the 52-week range of USD 30.71 to USD 66.99.
• NIO stock price has declined 29.51% and 19.93% in the past nine and twelve months, respectively.

Technical Price Chart (as of November 19, 2021). Analysis by Kalkine

Conclusion: Considering the significant losses, margins pressure, and technical indicators, we recommend a "Watch" rating on the stock at the current price of USD 38.80, up 1.02% as of November 19, 2021, at 12:02 PM ET.

*The reference data in this report has been partly sourced from REFINITIV.

NewAge, Inc.

NewAge, Inc. (NASDAQ: NBEV) is a company that develops, sells, and distributes a portfolio of healthy goods mainly through a direct to customer business model, with the support of a team of brand partners and distributors to advertise and sell the portfolio of brands.

Key Highlights

• The company reported an 84.67% increase in net revenues to USD 349.11 million during 9MFY21 (ended September 30, 2021) compared to USD 189.05 million during 9MFY20.
• In addition, NBEV reported a decline in a net loss to USD 3.10 million during 9MFY21 from USD 35.31 million during 9MFY20.
• Its reinvestment rate and net margin declined to -1.2% and -2.7% in Q3FY21 vs. 8.4% and 14.0% in Q2FY21, respectively.
• On November 16, 2021, NBEV announced the discovery of a novel mechanism of action for combating the effects of ageing and the submission of a new patent to preserve the discovery's originality.
• The stock is currently trading below its key short-term (50-day) and long-term (200-day) DMA support levels, with the RSI Index at 28.74, indicating an oversold zone.
• It is leaning towards the lower band of the 52-week range of USD 1.16 to USD 4.55.
• NBEV's stock price has declined 45.25% and 61.59% in the past six and nine months, respectively.

Technical Price Chart (as of November 19, 2021). Analysis by Kalkine

Conclusion: Considering the macroeconomic conditions, margins pressure, and technical indicators, we recommend a "Watch" rating on the stock at the current price of USD 1.21, down 2.42% as of November 19, 2021, at 12:06 PM ET.

*The reference data in this report has been partly sourced from REFINITIV. 

Disclaimer

The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.